European Archives - Page 1104 of 1343 - European Medical Journal

This site is intended for healthcare professionals

Continue
12 Mins
31 Oct 2017

Session Two: Changing the Type 2 Diabetes Mellitus Management Paradigm with Fixed-Ratio Combinations

Fixed-ratio combinations, the co-administration of two injectable therapies in a formulation that can be adjusted through titration, are changing the…
2 Mins
31 Oct 2017

Short-Term Renal Effects of Vildagliptin Addition and Their Clinical and Laboratory Predictors in Insulin-Treated Type 2 Diabetes Mellitus Patients: A Randomised, Comparative, Prospective Clinical Study

Positive renal effects of vildagliptin have been shown by several experimental studies.1,2 Nonetheless, clinical evidence for its renoprotective…
19 Mins
31 Oct 2017

Session Three: Innovating Beyond Glucose Control in Diabetes Care

Advances in treatment offerings are moving beyond classical considerations around glucose control to focus on other aspects of the disease.
2 Mins
31 Oct 2017

Acute Endothelial Benefits of Fat Restriction Over Carbohydrate Restriction in Type 2 Diabetes Mellitus

The current ‘Western cluster’ of non-communicable disorders could be redefined as a dysfunction of the heterogenic, complex, and bidirectional metabolic…
10 Mins
31 Oct 2017

Editor’s Pick: Addressing Hypertension in the Patient with Type 2 Diabetes Mellitus: Pathogenesis, Goals, and Therapeutic Approach

Hypertension is considered a powerful cardiovascular risk factor and is present in up to two-thirds of patients who suffer from diabetes. In the…
10 Mins
31 Oct 2017

Future Treatments of Diabetic Retinopathy: Pharmacotherapeutic Products Under Development

Diabetic macular oedema (DMO) is the leading cause of vision loss in working aged individuals. Macular laser photocoagulation was the primary DMO…
2 Mins
31 Oct 2017

Duration-8 Randomised Controlled Trial 1-Year Results: Efficacy and Safety of Once-Weekly Exenatide Plus Once-Daily Dapagliflozin Versus Exenatide or Dapagliflozin Alone

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors have complementary mechanisms of action.
8 Mins
31 Oct 2017

Role of Probiotics in Diabetes: A Review of Their Rationale and Efficacy

The efficacy of probiotics in diabetes has been proven by their ability to lower fasting glucose and insulin levels in a preclinical setting as well as in human trials.
2 Mins
31 Oct 2017

Favourable Adiposity’ Genes Provide Evidence that some People Are Fat on The Outside but Thin on The Inside

Higher BMI is associated with an adverse metabolic effect and a higher risk of Type 2 diabetes mellitus (T2DM), heart disease, and hypertension. However…
2 Mins
31 Oct 2017

SOCS2-/- Mouse as A Potential Model of Macrosomia and Gestational Diabetes

Fetal macrosomia, a complication of gestational diabetes (GD), is associated with negative maternal and neonatal outcomes. Macrosomic newborns have…
We’ve noticed you’re accessing
from North/South America.